Abstract
Allergen-specific immunotherapy for grass pollen allergy has been reported to be effective in up to 85 % of patients. Sensitisation to profilin and calcium-binding protein (CBP) can possibly influence treatment results and may thus be a reason for treatment failures. During a study period of 3 years, the distribution patterns of antibodies to marker allergens were continuously investigated in all blood serum samples with a level of immunoglobulin E antibodies to timothy and birch pollen higher than 0.7 kUA/l (n = 556). Sensitisation to timothy grass pollen alone was found in 33 % of the cases, to birch pollen alone in 19 %, and to both in 48 %. The group of polysensitised patients showed an inhomogenous distribution of antibodies to marker allergens. IgE against minor allergens was detected in 40 %. Sensitisation to major allergens, especially to the major birch allergen, was not present in 13 % of the polysensitised patients. Of the patients who were sensitised to minor allergens, 82 % were sensitised to profilin, 11 % to CBP, and 8 % to both profilin and CBP. Profilin and CBP frequently cause polysensitisations to pollen. The data obtained justify the measurement of serum levels of antibodies to marker allergens in patients who are sensitised to more than one group of allergens.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00405-013-2609-7/MediaObjects/405_2013_2609_Fig1_HTML.gif)
Similar content being viewed by others
References
van Ree R, van Leeuwen WA, Aalberse RC (1998) How far can we simplify in vitro diagnostics for grass pollen allergy? A study with 17 whole pollen extracts and purified natural and recombinant major allergens. J Allergy Clin Immunol 102:184–190
Valenta R, Duchene M, Ebner C et al (1992) Profilins constitute a novel family of functional plant pan-allergens. J Exp Med 175:377–385
Valenta R, Hayek B, Seiberler S et al (1998) Calcium-binding allergens: from plant to man. Int Arch Allergy Immunol 117:160–166
Sekerkova A, Polackova M, Striz I (2012) Detection of Phl p 1, Phl p 5, Phl p 7 and Phl p 12 specific IgE antibodies in the sera of children and adult patients allergic to phleum pollen. Allergol Int 61:339–346
Bousquet J, Lockey RF, Malling HJ (1998) WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic disease. J Allergy Clin Immunol 102:558–562
Larche M, Akdis CA, Valenta R (2006) Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 10:761–771
Valenta R, Ball T, Focke M et al (2004) Immunotherapy of allergic disease. Adv Immunol 82:105–153
Durham SR, Walker SM, Varga EM et al (1999) Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341:468–475
Moller HJ, Dreborg S, Ferdousi HA et al (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol 109:251–256
Calderon MA, Alves B, Jacobson M et al (2007) Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev (1):CD001936
Klimek L, Mewes T, Wolf H et al (2005) The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with systemic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity. Otolaryngol Head Neck Surg 133:538–543
van Ree R (2003) The CREATE project: a new beginning of allergen standardization based on mass units of major allergens. In: Löwer J, Becker W-M, Vieths S (eds) Regulatory control and standardization of allergenic extracts. Druck- und Verlagshaus Sperlich. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf a M, Frankfurt, pp 70–73 (discussion pp 74–75)
Valenta R, Lidholm J, Hayek B et al (1999) The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 29:896–904
Valenta R, Kraft D (2002) From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol 14:718–727
www.allergome.com. Accessed 18 Dec 2012
Ferreira F, Hawranek T, Gruber P et al (2004) Allergic cross-reactivity: from gene to the clinic. Allergy 59:243–267
Kazemi-Shirazi L, Niederberger V, Linhart B et al (2002) Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol 127:259–268
Andersson K, Lidholm J (2003) Characteristics and immunology of grass pollen allergens. Int Arch Allergy Immunol 130:87–107
Mari A, Wallner F, Ferreira F (2003) Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4). Clin Exp Allergy 33:1419–1428
Rossi RE, Monasterolo G, Monasterolo S (2003) Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles. Allergy 58:929–932
Asero R, Valenta D (2011) Are anti-Phl p 12 IgE levels predictive of oral allergy syndrome in profilin hypersensitive patients? Eur Ann Allergy Clin Immunol 43:184–187
Santos A, van Ree R (2011) Profilins: mimickers of allergy or relevant allergens? Int Arch Allergy Immunol 155:191–204
Weber RW (2007) Cross-reactivity of pollen allergens: impact on allergen immunotherapy. Ann Allergy Asthma Immunol 99:203–211
Mellon MB, Frank BT, Fang KC (2002) Mast cell alpha-chymase reduces IgE recognition of birch pollen profilin by cleaving antibody-binding epitopes. J Immunol 168:290–297
Grote M, Westritschnig K, Valenta R (2008) Immunogold electron microscopic localization of the 2 EF-hand calcium-binding pollen allergen Phl p 7 and its homologues in pollens of grasses, weeds and trees. Int Arch Allergy Immunol 146:113–121
Wopfner N, Dissertori O, Ferreira F, Lackner P (2007) Calcium-binding proteins and their role in allergic diseases. Immunol Allergy Clin North Am 27:29–44
Asero R, Jimeno L, Barber D (2010) Preliminary results of a skin prick test-based study of the prevalence and clinical impact of hypersensitivity to pollen panallergens (polcalcin and profilin). J Investig Allergol Clin Immunol 20:35–38
Twardosz-Kropfmueller A, Singh MB et al (2010) Association of allergic patients’ phenotypes with IgE reactivity to recombinant pollen marker allergens. Allergy 65:296–303
Canis M, Gröger M, Becker S, Klemens C, Kramer MF (2011) Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens. Am J Rhinol Allergy 25:36–39
Canis M, Gröger M, Becker S, Klemens C, Kramer MF (2010) Recombinant allergen profiles and health-related quality of life in seasonal allergic rhinitis. Allergy Asthma Proc 31:219–226
Schäfer T, Ring J (1997) Epidemiology of allergic diseases. Allergy 52(Suppl 38):14–22
Ring J, Bachert C, Bauer CP, Czech W (eds) (2009) Weißbuch Allergie in Deutschland, 3rd revised and extended edn, Urban & Vogel. ISBN: 3-89935-245-9, ISBN-13: 9783899352450
Conflict of interest
G.M. has received honoraria for scientific presentations from Phadia (Freiburg, Germany). H.M. declares no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muehlmeier, G., Maier, H. Polysensitisation to pollen due to profilin and calcium-binding protein: distribution of IgE antibodies to marker allergens in grass and birch pollen allergic rhinitis patients in southern Germany. Eur Arch Otorhinolaryngol 271, 719–725 (2014). https://doi.org/10.1007/s00405-013-2609-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-013-2609-7